Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial [0.03%]
同种异体ABCB5+间充质干细胞治疗难治性慢性静脉溃疡：一项I/IIa期临床试验
Andreas Kerstan,Kathrin Dieter,Elke Niebergall-Roth et al.
Andreas Kerstan et al.
A significant number of chronic venous ulcers (CVUs) fail to heal despite of guideline-conform standard of care. Skin-derived ABCB5+ mesenchymal stem cells (MSCs) can dampen the sustained IL-1β-driven inflammation present in chronic wounds...
Optimal biomechanical parameters for measuring sclerotic chronic graft-versus-host disease [0.03%]
测量硬化性慢性移植物抗宿主病的最佳生物力学参数
Laura X Baker,Fuyao Chen,Austin Cronin et al.
Laura X Baker et al.
Skin biomechanical parameters (dynamic stiffness, frequency, relaxation time, creep, and decrement) measured using a myotonometer (MyotonPRO) could inform management of sclerotic disease. To determine which biomechanical parameter(s) can ac...
Ashley Bui,Chunhui Jiang,Renee M McKay et al.
Ashley Bui et al.
Neurofibromatosis type 1 (NF1) is one of the most common neurocutaneous genetic disorders, presenting with different cutaneous features such as café-au-lait macules, intertriginous skin freckling, and neurofibromas. Although most of the di...
Differences in Melanoma Between Canada and New South Wales, Australia: A Population-Based Genes, Environment, and Melanoma (GEM) Study [0.03%]
加拿大与澳大利亚新南威尔士州黑色素瘤的差异——基于人群的基因、环境与黑色素瘤(GEM)研究
Joseph Michael Yardman-Frank,Elyssa Glassheim,Anne Kricker et al.
Joseph Michael Yardman-Frank et al.
In an effort to understand the difference between melanomas diagnosed in Australia (New South Wales) and Canada, where the incidence in New South Wales is almost three times greater than in Canada, and mortality is twice as high although su...